Condition: Diabetic Peripheral Neuropathic Pain · Sponsor: Vertex Pharmaceuticals Incorporated
The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine in participants with pain associated with diabetic peripheral neuropathy (DPN).
This description comes directly from the study's public registry record.
Medical Information · 6173416777 · medicalinfo@vrtx.com
Always discuss trial participation with your own doctor first.
| Central Research Associates, LLC | Birmingham, Alabama, United States | Recruiting |
| Accel Research - Birmingham | Birmingham, Alabama, United States | Recruiting |
| AMR Mobile | Mobile, Alabama, United States | Completed |
| Sun City Clinical Research | Glendale, Arizona, United States | Recruiting |
| Scottsdale Clinical Trials | Scottsdale, Arizona, United States | Recruiting |
| Lynn Institute of the Ozarks | Little Rock, Arkansas, United States | Recruiting |
| Hope Clinical Research | Canoga Park, California, United States | Recruiting |
| Marvel Clinical Research | Huntington Beach, California, United States | Recruiting |
| Eximia Research-CA, LLC | La Mesa, California, United States | Recruiting |
| Long Beach Research Institute | Long Beach, California, United States | Recruiting |
| Paradigm Clincial Research - Modesto | Modesto, California, United States | Recruiting |
| Pasadena Clinical Trials | Pasadena, California, United States | Recruiting |
+ 63 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07231419